Mechanism of inhibition of reverse transcriptase by quinone antibiotics. II. Dependence on putative quinone pocket on the enzyme molecule.
- 1 January 1988
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 41 (10) , 1471-1478
- https://doi.org/10.7164/antibiotics.41.1471
Abstract
Inhibition of avian myeloblastosis virus (AMV) reverse transcriptase by natural and synthetic quinones including antibiotics could be accounted for by an oxidation-reduction reaction. The quinones were shown to function as electron acceptors as revealed by the catalytic oxidation of NADH by Clostridium kluvveri diaphorase which was in excellent agreement with enzyme inhibition activity. The kinetics of inhibition of AMV reverse transcriptase by three synthetic quinones with different core structures, i.e., 6-methoxy-5,8-dihydroquinoline-5,8-dione, 5,8-dihydroisoquinoline-5,8-dione and 1,4-naphthoquinone, were studied. These quinones inhibited reverse transcriptase in the same manner as streptonigrin (STN) and were shown to act at a single class of reaction site(s) on the enzyme molecule. In contrast, the quinones with bulky substituents, i.e., 7-(2-nitrophenethylamino)-5,8-dihydroisoquinoline-5,8-dione and 7-methyoxy-6-methyl-3-piperidino-5,8-dihydroisoquinoline-5,8-dione, were inactive as inhibitors of reverse transcriptase, whereas retained competent catalytic activities in the oxidation of NADH by C. kluyveri diaphorase. Based on these observations, the existence of a specific site of interaction on the enzyme molecule, referred to as a quinone pocket, was proposed. The quinone pocket might play a crucial role in the early sequence of events leading to the inhibition of reverse transcriptase by quinones including STN and sakyomicin A (SKM). Access of SKM to a quinone pocket might be restricted due to its bulky structure in the vicinity of the quinone group. This is inferred from unsuccessful inhibition of reverse transcriptase by the quinones with bulky substituents, resulting in much poorer inhibtion of reverse transcriptase in spite of more potent electron acceptor activity in the oxidation-reduction system as compared with those of STN.This publication has 8 references indexed in Scilit:
- Comparative study on biological activities of heterocyclic quinones and streptonigrin.The Journal of Antibiotics, 1987
- INHIBITION BY SAKYOMICIN A OF AVIAN-MYELOBLASTOSIS VIRUS REVERSE-TRANSCRIPTASE AND PROLIFERATION OF AIDS-ASSOCIATED VIRUS (HTLV-III/LAV)1986
- Synthesis of renierone, 7-methyoxy-1,6-dimethyl-5,8-dihydroisoquinoline-5,8-dione and N-formyl-1,2-dihydrorenierone, antimicrobial metabolites from a marine sponge, Reniera sp.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Role of the naphthoquinone moiety in the biological activities of sakyomicin A.The Journal of Antibiotics, 1986
- Effects of streptonigrin derivatives and sakyomicin A on the respiration of isolated rat liver mitochondria.The Journal of Antibiotics, 1986
- Synthesis of Novel Quinoline Quinols and Isoquinoline Quinols from QuinonesHETEROCYCLES, 1985
- Retrostatin, a new specific enzyme inhibitor against avian myeloblastosis virus reverse transcriptase.The Journal of Antibiotics, 1983
- Isolation and characterization of satellite antibiotics, mimosamycin and chlorocarcins from Streptomyces lavendulae, streptothricin source.The Journal of Antibiotics, 1976